Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000176677 | SCV000228368 | uncertain significance | not provided | 2015-01-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001040302 | SCV001203865 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-06-22 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 1239 of the RPGRIP1L protein (p.Val1239Met). This variant is present in population databases (rs142387463, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RPGRIP1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 195977). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002485146 | SCV002793509 | uncertain significance | Joubert syndrome 7; Meckel syndrome, type 5; COACH syndrome 3 | 2021-11-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271319 | SCV001452404 | uncertain significance | Familial aplasia of the vermis | 2019-11-11 | no assertion criteria provided | clinical testing |